News
Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the ...
As mothers of children with this disease, we have wept helplessly in recent months as friends — fellow members of a club we ...
The Sarepta saga continues, with the FDA slapping a clinical hold across all of the company’s investigational limb girdle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results